Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

OTTMUSG00000018259 Inhibitors

The inhibition of alpha-defensin 5-like precursor involves the disruption of various signaling pathways and cellular processes that are essential for its activation and function. Trifluoperazine, W-7 Hydrochloride, and Chlorpromazine are notable for their interaction with calmodulin-dependent processes, a critical component in the signaling mechanisms that activate alpha-defensin 5-like precursor. By inhibiting these pathways, these chemicals effectively reduce the protein's activation, leading to a decrease in its functional activity, which is vital for immune response mechanisms.

On the other hand, Thapsigargin and 2-Aminoethoxydiphenyl Borate (2-APB) primarily disrupt calcium signaling, a key modulator of alpha-defensin 5-like precursor activity. Thapsigargin, a SERCA pump inhibitor, raises cytosolic calcium levels, which in turn can inhibit the protein by disturbing the calcium-dependent signaling balance required for its function. Similarly, 2-APB's modulation of IP3 receptors leads to altered calcium signaling, subsequently inhibiting the protein's activity. ML-9, Bisindolylmaleimide I, and Staurosporine further contribute to this inhibitory effect by targeting kinases like myosin light-chain kinase (MLCK) and protein kinase C, disrupting the cytoskeletal and signaling pathways crucial for the protein's function. U73122, which inhibits phospholipase C, and Genistein, a tyrosine kinase inhibitor, also play a significant role in hindering the phosphorylation events and signaling cascades necessary for the activation of alpha-defensin 5-like precursor. Lastly, PD 98059 and SB 203580, which target MEK and p38 MAP kinase respectively, disrupt specific MAPK pathways, leading to a comprehensive inhibition of the protein's functional activity, as these pathways are intricately involved in its regulation and activation. These chemicals, through their targeted actions on various kinases and signaling molecules, collectively contribute to the functional inhibition of alpha-defensin 5-like precursor, highlighting the complex interplay of cellular signaling pathways in regulating protein activity.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

W-7

61714-27-0sc-201501
sc-201501A
sc-201501B
50 mg
100 mg
1 g
$166.00
$306.00
$1675.00
18
(1)

W-7 acts as a calmodulin antagonist. By inhibiting calmodulin, it disrupts the calcium/calmodulin-dependent pathways that are essential for the activation of alpha-defensin 5-like precursor. This disruption leads to a reduction in the functional activity of alpha-defensin 5-like precursor, as its activation is closely tied to these pathways.

Chlorpromazine

50-53-3sc-357313
sc-357313A
5 g
25 g
$61.00
$110.00
21
(1)

Chlorpromazine interacts with multiple neurotransmitter receptors in the brain and is known to interfere with calmodulin-dependent pathways. This interference can inhibit the activity of alpha-defensin 5-like precursor, as these pathways play a significant role in its activation and function within the immune response.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

Thapsigargin is a SERCA pump inhibitor which leads to an increase in cytosolic calcium levels. Elevated calcium levels can disrupt calcium-dependent signaling pathways, potentially inhibiting the activation and function of alpha-defensin 5-like precursor, which relies on regulated calcium signaling for its activity.

2-APB

524-95-8sc-201487
sc-201487A
20 mg
100 mg
$28.00
$53.00
37
(1)

2-APB modulates IP3 receptors and can alter calcium signaling in cells. Since alpha-defensin 5-like precursor's activity is dependent on calcium signaling pathways, modulation of these pathways by 2-APB can lead to an inhibition of the protein's function.

ML-9

105637-50-1sc-200519
sc-200519A
sc-200519B
sc-200519C
10 mg
50 mg
100 mg
250 mg
$112.00
$449.00
$673.00
$1224.00
2
(1)

ML-9 is a kinase inhibitor known to inhibit myosin light-chain kinase (MLCK). By inhibiting MLCK, ML-9 can affect cytoskeletal rearrangements and signaling pathways involved in the activation of alpha-defensin 5-like precursor, leading to its functional inhibition.

Bisindolylmaleimide I (GF 109203X)

133052-90-1sc-24003A
sc-24003
1 mg
5 mg
$105.00
$242.00
36
(1)

Bisindolylmaleimide I is a protein kinase C inhibitor. The inhibition of protein kinase C can lead to the disruption of signaling pathways necessary for the proper functioning of alpha-defensin 5-like precursor, resulting in its inhibition.

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

Staurosporine is a potent, non-selective inhibitor of protein kinases. By broadly inhibiting these kinases, it can disrupt multiple signaling pathways, including those that regulate the activity of alpha-defensin 5-like precursor, thus leading to its inhibition.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$45.00
$164.00
$200.00
$402.00
$575.00
$981.00
$2031.00
46
(1)

Genistein is a tyrosine kinase inhibitor. By inhibiting these kinases, it can disrupt the phosphorylation events crucial for the signaling pathways that activate alpha-defensin 5-like precursor, thereby inhibiting its function.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD 98059 is a specific inhibitor of MEK, which is involved in the MAPK/ERK pathway. Inhibiting MEK can disrupt the signaling pathway that is potentially involved in the activation of alpha-defensin 5-like precursor, leading to its inhibition.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB 203580 is a specific inhibitor of p38 MAP kinase. By inhibiting p38 MAP kinase, it can disrupt the signaling pathway that might be involved in the activation and function of alpha-defensin 5-like precursor, leading to its inhibition.